BNP Paribas Financial Markets
BBNX

BNP Paribas Financial Markets’s Beta Bionics BBNX Stock Holding History

BNP Paribas Financial Markets’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$162K Buy
10,323
+1,828
+22% +$21.7K ﹤0.01% 4328
2026
Q1 		$85.1K Sell
8,495
-193,397
-96% -$2.86M ﹤0.01% 4453
2025
Q4 		$6.15M Buy
201,892
+194,077
+2,483% +$5.18M ﹤0.01% 1908
2025
Q3 		$155K Buy
7,815
+6,587
+536% +$116K ﹤0.01% 4118
2025
Q2 		$17.9K Buy
1,228
+508
+71% +$7.19K ﹤0.01% 4655
2025
Q1 		$8.81K Buy
+720
New +$13.4K ﹤0.01% 4746

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

BNP Paribas Financial Markets's BBNX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Beta Bionics (BBNX) stake by 22% in Q2 2026, buying an estimated $21.7K and bringing the position to 10,323 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #4328.

BNP Paribas Financial Markets first reported a position in BBNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.15M in Q4 2025. 123 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • BNP Paribas Financial Markets held 10,323 shares of Beta Bionics worth $162K as of Q2 2026.
  • BNP Paribas Financial Markets bought 1,828 Beta Bionics shares in Q2 2026, an estimated $21.7K.
  • Beta Bionics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4328 holding.
  • BNP Paribas Financial Markets first reported a position in Beta Bionics in Q1 2025 and has held it in 6 quarters since.
  • BNP Paribas Financial Markets's Beta Bionics position peaked at $6.15M in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.